Hui, L.-A.; Vlase, A.-M.; Hirișcău, E.I.; Bodolea, C.; Bălan, A.-M.; Vlase, L.; Popa, A.
Effectiveness and Safety of Linezolid as Continuous Infusion Versus Intermittent Infusion in Critically Ill Patients: A Pilot Study. Future Pharmacol. 2025, 5, 61.
https://doi.org/10.3390/futurepharmacol5040061
AMA Style
Hui L-A, Vlase A-M, Hirișcău EI, Bodolea C, Bălan A-M, Vlase L, Popa A.
Effectiveness and Safety of Linezolid as Continuous Infusion Versus Intermittent Infusion in Critically Ill Patients: A Pilot Study. Future Pharmacology. 2025; 5(4):61.
https://doi.org/10.3390/futurepharmacol5040061
Chicago/Turabian Style
Hui, Ligia-Ancuța, Ana-Maria Vlase, Elisabeta Ioana Hirișcău, Constantin Bodolea, Andrei-Mihai Bălan, Laurian Vlase, and Adina Popa.
2025. "Effectiveness and Safety of Linezolid as Continuous Infusion Versus Intermittent Infusion in Critically Ill Patients: A Pilot Study" Future Pharmacology 5, no. 4: 61.
https://doi.org/10.3390/futurepharmacol5040061
APA Style
Hui, L.-A., Vlase, A.-M., Hirișcău, E. I., Bodolea, C., Bălan, A.-M., Vlase, L., & Popa, A.
(2025). Effectiveness and Safety of Linezolid as Continuous Infusion Versus Intermittent Infusion in Critically Ill Patients: A Pilot Study. Future Pharmacology, 5(4), 61.
https://doi.org/10.3390/futurepharmacol5040061
